Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience

BACKGROUND: Patients with triple-negative primary breast cancer (TNBC) who have residual invasive carcinoma after neoadjuvant chemotherapy have poor prognosis. Proven adjuvant approaches to reduce the risk of recurrence and improve outcome in patients with non-pathological complete response (non-pCR...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Care (Basel)
Main Authors: Stoetzer, Oliver, Di Gioia, Dorit, Issels, Rolf Dieter, Abdel-Rahman, Sultan, Mansmann, Ulrich, Lindner, Lars Hartwin, Gluz, Oleg, Würstlein, Rachel, Braun, Michael, Hamann, Moritz, Edler von Koch, Franz, Harbeck, Nadia, Salat, Christoph
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2021
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8114059/
https://ncbi.nlm.nih.gov/pubmed/34012372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000507473
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados